PSI Software AG (0KUR)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 45.40 |
|---|---|
| 52-week range | 40.10 – 46.90 |
| Return, 1 month / 3 months | +0.7% / +0.9% |
| Return, 1 year / 3 years | +0.7% / +97.4% |
| Trend | Uptrend |
| RSI (14) | 53 |
| Volatility (1 year) | 49.1% |
| Worst drawdown (1 year) | -17.8% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
PSI Software AG is a German software company based in Berlin that develops and supplies business software for managing complex operations. Its products support energy supply companies, industrial manufacturers and logistics and transport operators, covering areas such as grid management, production planning and control of operational processes. Customers use its systems to monitor and control technical infrastructure and to organise workflows across their organisations. The company also provides related consulting, implementation and maintenance services alongside its software.
The shares are listed on the London Exchange in UK under the code 0KUR, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
PSI Software AG (0KUR) trades on the London Exchange in UK. It last closed at EUR 45.40 on 19 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 2,255 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.7% and over the last three months it rose 0.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.6% | ||
| From 52-week high | -2.5% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.9% | ||
| 6-month return | -1.3% | ||
| 12-month return, skipping the last month | 0.0% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 49.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.8% | ||
| Liquidity | 6 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 25.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.8% |
|---|---|
| 1 month | +0.7% |
| 3 months | +0.9% |
| 6 months | −1.3% |
| 1 year | +0.7% |
| 3 years | +97.4% |
| 5 years | +19.0% |
Signals
| 50-day / 200-day average | 44.99 / 45.15 |
|---|---|
| Golden / death cross (60 days) | Death, 21 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.91 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 May 2023 | EUR 0.4000 |
| 20 May 2022 | EUR 0.4000 |
| 20 May 2021 | EUR 0.3000 |
| 10 Jun 2020 | EUR 0.0500 |
| 17 May 2019 | EUR 0.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.